エピソード

  • Living With and Treating Multiple Sclerosis: A Physician's Dual Perspective

    Living With and Treating Multiple Sclerosis: A Physician's Dual Perspective
    2026/08/18
    How does living with multiple sclerosis change the way a physician cares for patients? In this episode of MS Masters, Parisa Khosravi, MD, of Central Texas Neurology Consultants, Round Rock, TX—an MS specialist who has lived with the disease for more than a decade—discusses how her experiences on both sides of the exam room have shaped her approach to communication, shared decision-making, and long-term MS management.
    続きを読む 一部表示
    15 分
  • Multiple Sclerosis and Migraine: Diagnosis, MRI Clues, and Treatment Strategies

    Multiple Sclerosis and Migraine: Diagnosis, MRI Clues, and Treatment Strategies
    2026/07/28
    Migraine affects approximately 1 in 4 people living with multiple sclerosis (MS), making accurate diagnosis and management essential. In this episode, Beverly Gilder, MD, Advanced Neurology of Colorado – Denver South, Denver, CO, discusses strategies to distinguish migraine from MS activity using patient history, MRI findings, and clinical presentation as well as practical treatment considerations.
    続きを読む 一部表示
    14 分
  • Guideline-Driven Strategies in MS: De-escalating and Discontinuing Disease-Modifying Therapies

    Guideline-Driven Strategies in MS: De-escalating and Discontinuing Disease-Modifying Therapies
    2025/09/04
    In this episode, Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, discusses the first comprehensive recommendations for de-escalating and discontinuing disease-modifying therapies in select individuals living with multiple sclerosis developed by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
    続きを読む 一部表示
    13 分
  • New Guidelines for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Rethinking Hematopoietic Stem Cell Transplantation

    New Guidelines for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Rethinking Hematopoietic Stem Cell Transplantation
    2025/08/25
    Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, reviews the latest international guidelines from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and EBMT on the use of autologous hematopoietic stem cell transplantation (AHSCT) in relapsing multiple sclerosis and neuromyelitis optica spectrum disorder.
    続きを読む 一部表示
    12 分
  • The Optic Nerve in Multiple Sclerosis

    The Optic Nerve in Multiple Sclerosis
    2025/02/26
    Peter Sguigna, MD, Assistant Professor, UT Southwestern, Dallas, TX, discusses recent updates related to the optic nerve in the 2024 McDonald diagnostic criteria for multiple sclerosis (MS) along with the importance of considering neuro-ophthalmology findings when caring for patients with MS.
    続きを読む 一部表示
    11 分
  • Subcutanous Ocrevus Zunovo as a New Treatment Option for Multiple Sclerosis

    Subcutanous Ocrevus Zunovo as a New Treatment Option for Multiple Sclerosis
    2024/12/11
    In this episode, Scott D. Newsome, DO, Professor of Neurology, Johns Hopkins University, Baltimore, MD, discusses how Ocrevus Zunovo can be used to treat primary progressive and relapsing forms of multiple sclerosis, including how the drug is administered, research related to the efficacy of this formulation, and the impact on clinical practice and patients.
    続きを読む 一部表示
    15 分
  • 2024 McDonald Diagnostic Criteria for Multiple Sclerosis

    2024 McDonald Diagnostic Criteria for Multiple Sclerosis
    2024/11/20
    Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, provides an overview of the 2024 McDonald diagnostic criteria for multiple sclerosis including what's changed, the rationale for updates, and next steps in implementing the recommendations.
    続きを読む 一部表示
    10 分
  • 10-year Study Data Shows Reduced Disability in MS Patients Treated with Ocrevus

    10-year Study Data Shows Reduced Disability in MS Patients Treated with Ocrevus
    2024/07/15
    Robert Bermel, MD, Director of the Mellen Center for Multiple Sclerosis,Cleveland Clinic, provides an overview of the 10-year study data demonstrating Ocrevus treatment reduces disability in participants with MS.
    続きを読む 一部表示
    11 分